Predicting Resistance to Immunotherapy in Melanoma, Glioblastoma, Renal, Stomach and Bladder Cancers by Machine Learning on Immune Profiles
Strategies for tackling cancer involve surgery, radiotherapy, chemotherapy, and immune checkpoint inhibitors (ICB).However, the effectiveness of ICB remains constrained, prompting the need for a proactive strategy to foresee treatment responses and resistances.This study undertook an analysis across diverse cancer patient cohorts (including melanom